Forms Processing
PRODUCTS
-
Small molecule drugs are chemical compounds that have a low molecular weight, typically below 900 daltons. Due to their small size and chemical characteristics, small molecule drugs are well-suited to enter the gastrointestinal tract and quickly absorb into the bloodstream. Additionally, they can easily pass through cell membranes to exert their therapeutic effects. Today it’s estimated that small molecules account for 90% of drugs in the market. One reason they’re so popular and patient-friendly is that they can be taken orally, which makes them convenient for all ages.
-
Capture data at the true source: the patient. Improve the patient experience with secure, accessible questionnaires both via email and through the Castor Connect mobile application.
-
Recognized globally as a CNS Center of Excellence, Altasciences has completed more than 200 preclinical and clinical neurological studies, in addition to providing formulation, manufacturing, and analytical testing services, as well as bioanalytical support. Speak with one of their experts!
-
For successful regulatory outcomes, we provide quality medical writing services for clinical trial documents, safety updates, and marketing applications.
-
Elevate Your Clinical Research Data Collection
WHITE PAPERS AND CASE STUDIES
-
Increasing Participation In World-Class Cancer Research In Northwest Arkansas
Discover how data automation and integrated screening help community cancer centers offer clinical research as a standard care option, ensuring all patients have access to the latest treatments.
-
Powering More Efficient Clinical Development With AI And ML
Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.
-
Tablet Manufacturing Technologies For Solid Drug Formulation
Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.
-
How A Pharma Company Improved Yield By 1.5% In Just Three Months
A pharma company faced a 4% yield drop and variability at a manufacturing facility. Explore how they leveraged an AI-based platform to unify data, pinpoint inefficiencies, and enhance consistency in yields.
-
Elevating Diverse Patient Voices To Inspire Clinical Trial Participation
Explore the innovative approach taken during this clinical trial partnership to address the underrepresentation of minority communities in clinical trials through digital storytelling.
-
Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study
This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
Quantitation Of Monoclonal Antibodies In Serum
Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development.
-
Catalent's Journey Of Continuous Improvement For CSV Excellence
Learn how organizations must continuously reassess validation processes and digital tools to ensure compliance, enhance efficiency, and support global scalability amidst evolving regulatory expectations.
-
Bringing In Vitro Diagnostics To Market With Real-World Evidence
Explore the potential of real-world evidence in enhancing the regulatory decision-making process to facilitate the market entry of IVDs.
-
A Risk-Based Approach To Plasmid DNA And mRNA Process Development
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation
Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.
NEWS
-
Xanadu And Thorlabs Partner To Advance Optical Controls For Photonic Quantum Computing1/13/2026
Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, and Thorlabs, a globally-renowned designer and manufacturer of photonics equipment, have partnered to develop customized optical fiber components essential for realizing large-scale photonic quantum computing.
-
Lyzr Launches Enterprise-Grade AI Agents For Procurement Across Sourcing And Vendor Management1/22/2026
Lyzr announced the launch of its AI-powered Procurement Agents, a new category of autonomous agents designed to modernize sourcing, procurement, and vendor management across large enterprises.
-
Seagate Ships 30TB Drives To Meet Global Surge In Data Center AI Storage Demand7/15/2025
Seagate Technology Holdings plc, a global leader in mass-capacity data storage, today announced the global channel availability of up to 30TB Exos M and IronWolf Pro hard drives.
-
MapleTech Introduces Aspire Quick Start2/10/2026
Maple Technologies (MapleTech), developer of the Aspire suite, a platform of integrated modules for processing personal and commercial Property & Casualty insurance, announces the availability of Quick Start, a step-by-step workflow embedded in the Aspire underwriting platform that automates trucking insurance risk intake.